Leucocare AG Martinsried/München News & Veranstaltungen

Archiv

Press Releases

Sep. 2017

 LEUKOCARE continues to expand and invests in research and development

(more...)
Feb. 2017

Rentschler and Leukocare announce strategic alliance and equity investment

(more...)
Sep. 2016

LEUKOCARE grants license to US vaccine company PaxVax 

(more...)
Jul. 2016

Dr. Andreas Rummelt, pharma industry expert and former CEO of Sandoz, was elected as new supervisory board member at LEUKOCARE’s annual shareholder meeting on July 12th.

 

(more...)
Mar. 2016

LEUKOCARE launches comprehensive website update

(more...)
Jul. 2015

LEUKOCARE receives growth capital funding by LifeCare Partners and strengthens its board with industry experts

(more...)
Apr. 2015

LEUKOCARE participates in European consortium to validate blood-based biomarkers for cancer

(more...)
Apr. 2014

New book release covering Biofunctional Surface Engineering of medical devices

(more...)
Mar. 2014

LEUKOCARE is pleased to announce the launch of its new website in March 2014

(more...)
Dec. 2013

LEUKOCARE licenses its stabilizing and protecting technologies for veterinarian vaccine

(more...)
Oct. 2013

Scil Proteins and LEUKOCARE develop a stabilized recombinant human thrombin manufactured in bacteria

(more...)
Oct. 2013

Innovative Influenza A vaccine formulation increases stability and provides new options for production and storage

(more...)
Oct. 2013

Xenios and LEUKOCARE announce strategic partnership in the field of anti-inflammatory coatings for next generation extracorporeal support systems

(more...)
Sep. 2013

LEUKOCARE announces EUR 3.4 M capital increase

(more...)
May. 2013

LEUKOCARE in collaboration with Technical University Munich (TUM) develops a novel HBV vaccine and receives grant by German government

(more...)
Oct. 2012

LEUKOCARE licenses biomarker cell-free DNA to Trillium Diagnostics

(more...)
Sep. 2012

LEUKOCARE to publish scientific findings and background of its SPS®-technology in Materials Today

(more...)
Jul. 2012

LEUKOCARE provides key technologies for tumour diagnosis in personalized medicine research project

(more...)
Feb. 2012

LEUKOCARE to receive Frost & Sullivan’s prestigious 2011 Biotechnology Investment Opportunity Award

(more...)
Dec. 2011

LEUKOCARE´s QM System Passes Surveillance Audit Successfully

(more...)
Oct. 2011

German Ministry of Economics Grants Nonrefundable Subsidies to LEUKOCARE for Development of Functional Coatings in Orthopedic Implants

(more...)
Jul. 2011

Sanofi-Pasteur evaluates LEUKOCARE’s SPS® technology for vaccine stabilization

(more...)
Nov. 2010

LEUKOCARE signs cooperation agreement with Sterigenics

(more...)
Jun. 2010

LEUKOCARE appoints VP Business Development

(more...)
Feb. 2010

LEUKOCARE has been granted both ISO 9001 and ISO 13485 certification

(more...)
Dec. 2009

Grant of LSM patent

(more...)
Jul. 2009

Successful completion of LIMFRA-Study

(more...)
Sep. 2008

LEUKOCARE announces 2.1 Mio EUR capital increase

(more...)
Oct. 2005

Start of clinical trial for Leukocyte Inhibition Module (LIM)

(more...)
Back